Lead

About This Project

The lifetime risk of developing colorectal cancer (CRC) is about 1 in 22 for men and 1 in 24 for women and this risk increases with age. CRC represents 22% of the total cancer-related costs. It usually begins as a non-cancerous growth called a polyp that develops on the inner lining of the colon or rectum and grows slowly over a period of 10 to 20 years. Research has confirmed that the single best prevention for colon cancer is the early detection and removal of all colon polyps. When colorectal cancer is found at an early stage, the 5-year relative survival rate is about 90% which makes it suitable for screening programs.

 

LEAD (LEsion Auto-Detector) is a cost-effective, disposable miniature colon spectral scanner that drastically improves polyp detection (99%). It features a 360° light emitting ring that scans the colon, automatically processes different wavelengths from the reflected spectral data and provides real-time alerts based on accurate pathological tissue analysis.

Topic
PHC-12 - Clinical research for the validation of biomarkers and/or diagnostic medical devices
Year

2018

Cutoff

February

Beneficiaries

Coordinator

SINGER

Country

Israel

Website

Link